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The MRI signal is dependent upon a number of sub-voxel properties of tissue, which makes it potentially able to detect changes occurring at a scale much smaller than
the image resolution. This “microstructural imaging” has become one of the main branches of quantitative MRI. Despite the exciting promise of unique insight beyond
the resolution of the acquired images, its widespread application is limited by the relatively modest ability of each microstructural imaging technique to distinguish
between differing microscopic substrates. This is mainly due to the fact that MRI provides a very indirect measure of the tissue properties in which we are interested. A
strategy to overcome this limitation lies in the combination of more than one technique, to exploit the relative contributions of differing physiological and pathological
substrates to selected MRI contrasts. This forms the basis of multi-modal MRI, a broad concept that refers to many different ways of effectively combining information
from more than one MRI contrast. This paper will review a range of methods that have been proposed to maximise the output of this combination, primarily falling
into one of two approaches. The first one relies on data-driven methods, exploiting multivariate analysis tools able to capture overlapping and complementary in-
formation. The second approach, which we call “model-driven”, aims at combining parameters extracted by existing biophysical or signal models to obtain new
parameters, which are believed to be more accurate or more specific than the original ones. This paper will attempt to provide an overview of the advantages and
limitations of these two philosophies.Introduction
Magnetic resonance imaging (MRI) has had an unprecedented
contribution to our understanding of the brain, thanks to its ability to
take extremely detailed pictures of this organ non-invasively. As our
understanding of the MR signal increased, and hardware development
allowed us to push the boundaries further and further, a range of image
contrasts, each reflecting different properties of the tissue, has
become available.
This has prompted a shift from qualitative to quantitative MRI that
represented a true revolution in the application of MRI for research
(Tofts, 2003a), particularly with the development of techniques able to
detect changes occurring at the microstructural level.
Most of these techniques have proven extremely sensitive to tissue
abnormalities, albeit at the price of poor specificity. The MRI signal is a
very indirect measure of the tissue properties we are interested in, and
despite the influence that factors such as myelin content and axonal
packing have on the contrast, the variety of factors that contribute to the
overall signal prevents a one-to-one association between MRI biomarkers
and biological substrate. In order to overcome this intrinsic limitation of
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(such as axon diameter or permeability), e.g (Alexander et al., 2010;
Coatleven et al., 2014; Kaden and Alexander, 2013). However, these
applications remain associated with prohibitively long scan times and
poor reproducibility.
How can we access non-invasive imaging biomarkers with improved
specificity?
The answer lies in the versatility of MRI: by combining several MRI
contrasts we can exploit the relative contributions of differing patho-
logical substrates to selected MRI contrasts and substantially increase the
sensitivity to specific substrates. A way of picturing this is by imagining
that many tissue components have been “encoded” via different filters in
each MRI technique. Multi-modal MRI is thus the way to decode them.
Multi-modal MRI is a broad concept that refers to any attempt to
combine information coming from more than one MRI contrast. The
possible approaches thus span from simply measuring several MRI pa-
rameters in the same individuals, to developing joint models, to using
complex computational approaches to derive new measures.
In this paper we will review some examples of multi-modal imaging
with the aim of identifying the advantages of this approach while high-
lighting at the same time the challenges and pitfalls associated with it.9RR, Brighton, East Sussex, UK.
der the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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components of brain tissue that we may want to characterise, and the
MRI techniques that so far hold the most promise for achieving this goal.
Next we will discuss the evidence that supports the complementarity of
some of these techniques. Finally, we will review the most popular
methods for the acquisition and analysis of multi-modal data.
What are we trying to measure?
The aim of microstructural imaging is to quantify the properties of
tissue components, such as myelin, axons, dendrites, glia, and to char-
acterise pathological features such as demyelination, inflammation,
axonal loss. In other words, the ultimate goal of microstructural imaging
is to be able to provide non-invasive histology. While the same principles
apply to the study of white and grey matter, this paper will focus pri-
marily on the former tissue. This is because most of the work done to date
concerns the white matter, and models of the MRI signal in white matter
are usually less ambiguous than those of the grey matter.
The white matter of the human brain is composed by tightly packed
myelinated and non-myelinated axons and glial cells. The glial cells
include oligodendrocytes, astrocytes, microglia, and oligodendrocyte
progenitor cells (Walhovd et al., 2014). Pathology in the white matter
thus consists mainly of demyelination, axonal degeneration and loss, and
gliosis. In addition, iron, which is stored in the ferritin protein, tends to
accumulate with age and neurodegenerative processes, although its
concentration levels are higher in the grey matter (particularly in the
basal ganglia) than in white matter (Connor et al., 1990; Hallgren and
Sourander, 1958). Similar changes are induced to MRI biomarkers by
each and/or a combination of these abnormalities, complicating their
interpretation. Most MRI parameters tend to share some degree of vari-
ance, and disentangling these contributions is essential to understand the
pathophysiology of neurological disorders and therefore to develop
treatments. In addition to disease, measuring white matter changes is
also relevant to understanding the mechanisms underpinning plastic
changes occurring to the brain as a consequence of maturation, ageing,
training and lifestyle (Kleim et al., 2002; Scholz et al., 2009; Zatorre
et al., 2012).
How are we trying to measure it?
Here we will provide a brief overview of some basic concepts that
may be needed to understand the following sections. While an extensive
review of each technique is beyond the scope of this paper, interested
readers can refer to the references provided below for more details. This
list of techniques is not meant to be exhaustive: other MRI methods that
offer insight into microstructure exist. Here we have included the most
popular ones and also those that so far have been most consistently
combined in a multi-modal fashion.
Diffusion MRI
The contrast in diffusion MRI (dMRI) arises from the interaction be-
tween the random motion of water molecules and the obstacles (consti-
tuted by membranes, organelles, cells, etc) they encounter within tissue
(LeBihan, 1990). If such obstacles are not distributed uniformly, but
rather form ordered “barriers” to diffusion, then diffusion becomes
anisotropic. Diffusion tensor imaging (DTI) can model diffusion anisot-
ropy, and allows a number of scalar indices to be derived, that can be
used to characterise tissue microstructure (Basser et al., 1994). Fractional
anisotropy (FA) has become one of the most popular MRI-derived indices
in clinical studies, and it has been applied to the study of many neuro-
logical and psychiatric disorders (Pierpaoli et al., 1996). However,
changes to anisotropy are difficult to interpret because different effects,
such as myelin loss and axonal degeneration, could result in the same FA
change (Beaulieu, 2009). A more comprehensive picture can be gained
by looking at the eigenvalue changes at the same time, or at the so-called
axial (AD) and radial (RD) diffusivities (Song et al., 2005). However, care118must be taken, as axial and radial diffusivity may be meaningless in re-
gions of crossing fibres (Wheeler-Kingshott and Cercignani, 2009). This
is a consequence of the diffusion tensor being inadequate to describe
diffusion in such a system. dMRI has evolved over the years to account for
these problems, yielding more complex models, which can account for
more than one fiber bundle per voxel, and even for multiple compart-
ments. Many of these advanced models (e.g., diffusion kurtosis imaging
(Jensen et al., 2005)) increase sensitivity to microstructural changes but
still do not provide specific information about the nature of the detected
changes. More direct measurements of specific features, such as axonal
density of radius, can in principle be achieved (Alexander et al., 2010)
exploiting dMRI, but they require prohibitively long acquisition times
and specialised equipment.
Magnetization transfer imaging
Magnetization transfer (MT) is based on the exchange of magnetiza-
tion occurring between groups of spins characterised by different mo-
lecular environment (Wolff and Balaban, 1989), namely those in free
water and those bound to lipids and proteins. It is generally accepted that
myelin dominates this process in the white matter. While MT imaging has
been available for 3-4 decades now, the traditional approach to quantify
it was based on the so-called MT ratio (MTR) (Dousset et al., 1992). MTR
is the percentage difference of two images, one with off-resonance
saturation (to which only macromolecular protons are sensitive) and
one without. By increasing the number of acquisitions to 3, it becomes
possible to separate the contributions of MT and T1, and therefore to
reduce the impact of other factors, including the T1-shortening effects of
iron, on image contrast (Helms et al., 2008). Analytical models of the
MT-weighted signal exist (Henkelman et al., 1993), where each pool is
characterised by their longitudinal relaxation rates (RA and RB), their
transverse relaxation times (T2A and T2B), and their spin densities (M0A
and M0B). The exchange rate constant between the pools is R. Assuming
that myelin is the main contributor to MT in white matter, the ratio
M0B/M0A, known as the pool size ratio (PSR or F), is believed to reflect
myelin content. Some Authors prefer to use the bound pool fraction (BPF)
which is given by M0B/(M0B þ M0A). Several animal studies support this
assumption (Ou et al., 2009b; Turati et al., 2015). MT is also known to be
sensitive to inflammation and pH (Henkelman et al., 2001; Louie et al.,
2009), and consistently it was recently suggested that MT parameters
other than F might be sensitive to activated microglia or astrocytosis
(Harrison et al., 2015) and metabolism (Giulietti et al., 2012). One of the
limitations of MT is that typically the quantification of macromolecular
protons is relative to the amount of liquid protons. This of course makes it
impossible to distinguish between cases of increased water (e.g.,
oedema) and decreased lipid-proteins (e.g., demyelination) (Stanisz
et al., 2004). In addition, macromolecules other than myelin might affect
MT measurements.
T1, T2, T2*, and T2’ relaxometry
T1 and T2 are known to be extremely sensitive to white matter
microstructure (Kucharczyk et al., 1994). The properties of myelin, in
particular, cause the relaxation times of the water trapped within its
layers to be much shorter than those of intra and extracellular water
(MacKay et al., 1994). This can be exploited in multi-component relax-
ometry, also known as multi-exponential T2 (MET2). The technique in-
volves sampling the signal at several echo-times, and estimating the
spectrum of T2-values (MacKay et al., 2006), with each peak corre-
sponding to a different water component. In a departure from the original
technique, the multi-component driven equilibrium single pulse obser-
vation of T1 and T2 (mcDESPOT) approach (Deoni et al., 2003) allows
whole brain myelin water fraction (MWF) maps to be obtained in under
10 min. One of the differences between mcDESPOT and MET2 is in the
assumptions made about water exchange. While MET2 methods typically
assume there is no exchange, such an assumption has been questioned
particularly in the presence of myelin thinning. Neglecting this term
might lead to underestimating the myelin water fraction, and should be
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The signal in gradient echo sequences decays with a faster time
constant than T2, due to the presence of local external magnetic field
inhomogeneities causing an additional dephasing of the magnetization.
This shorter decay time is known as T2*. T2* is related to any factor
causing local susceptibility changes such as the presence of iron (Haacke
et al., 2005).
R2’ (¼1/T2’), defined as the difference between 1/T2* and 1/T2,
should provide a more direct measure of field inhomogeneities and thus
of iron (Ordidge et al., 1994). However, this parameter tends to be small
in magnitude and often affected by noise, which limits its precision, and
its use.
T2* contrast is also exploited in techniques such as blood-
oxygenation level dependent (BOLD) contrast, arterial spin labelling,
and susceptibility-weighted imaging.
Quantitative susceptibility mapping
Quantitative susceptibility mapping (QSM) is becoming increasingly
popular (Wharton et al., 2010). Magnetic susceptibility is related to iron
content, myelin properties, fiber orientation and blood flow (Haacke
et al., 2005), and thus QSM has great potential in the context of micro-
structural imaging. This technique aims at measuring quantitatively the
local magnetic susceptibility independently from the sample orientation.
The data are acquired typically using flow-compensated gradient echo
images, with a set of parameters that depend on the tissue of interest
(Haacke et al., 2015). The relevant information is contained in the phase
of the MRI signal, and require careful processing in order to be extracted.
The processing includes phase-unwrapping (i.e. removing the disconti-
nuities caused by the fact that the phase is defined between -π and π) and
removal of background fields caused by bulk field inhomogeneities. Once
the local magnetic field is estimated, estimating the magnetic suscepti-
bility requires the inversion of an ill-posed problem, and only recently
appropriate reconstruction methods have become available (e.g.,(Liu
et al., 2009; Schweser et al., 2013; Shmueli et al., 2009). Thanks to these
developments, and to the advent of ultra-high magnetic fields for human
MRI, QSM has become feasible in vivo, and it has been applied to the
study of iron distribution, demyelination and oxygen metabolism (Wang
and Liu, 2015).
Proton density quantification
The proton density (PD) quantifies the amount of MR-visible protons
contributing to the MRI signal and therefore it is related to the tissue
water content. Water content variations are often associated with path-
ological processes such as oedema but also with maturation and ageing
(Neeb et al., 2006). In addition, assuming that the MR-visible protons in
the brain correspond to the “liquid” protons in free water, it has been
suggested that the quantity (1-water content) can be used as a measure of
the macromolecular content, in the form of macromolecules and lipid
tissue volume or MTV (Mezer et al., 2013). The MRI signal intensity is
intrinsically proportional to PD through the equilibrium magnetization
M0; exact quantification, however, is hampered by a number of con-
founding factors, including field inhomogeneities and receiver coil pro-
file (Tofts, 2003b). Once M0 is known, a quantitative estimation of the
water content requires some kind of calibration, in order to normalize PD
values to a pure water standard. Thanks to the development of accurate
methods to correct for the bias, recently PD quantification has
gained momentum.
1H MR spectroscopy
MR spectroscopy (MRS) measures the concentration of chemical
compounds (known as metabolites) that contain hydrogen (1H). Other
nuclei can be studied (e.g., phosphorus, sodium or fluorine), but here we
will focus on 1H MRS. The physical principle behind MRS is “chemical
shift”, i.e. the difference in resonant frequency between each metabolite
and water. This difference depends on the ‘electron cloud’ (Buonocore
and Maddock, 2015), a term that refers to the field produced by the119electrons surrounding the nucleus. Thanks to chemical shift, a spectrum
showing the peak resonant frequency of each metabolite can be obtained
using MR. The peak area is estimated as a measure of relative concen-
tration. Themetabolites of greatest interest are: N-acetyl-aspartate (NAA)
which is seen only in neurons and axons and is believed to reflect both
density and function of nervous cells; choline (Cho), a marker of mem-
brane turnover, typically elevated in tumours; Creatine (Cr), which is
often used as a reference for quantifying other metabolites; myo-inositol
(mI), a glial cell marker; and lastly Glutamateþ Glutamine (Glx), Lactate,
and GABA. Absolute quantification of metabolite concentration is chal-
lenging, and thus often it is expressed as a ratio between themetabolite of
interest and another one (typically Cr), which is assumed to remain stable
in the condition under study. This is, however, not ideal, as changes to Cr
have been observed for example in tumours (Hattingen et al., 2008;
Howe et al., 2003).
Imaging using multiple modalities: overlapping or complementing
information?
The possibility of measuring many different physical quantities non-
invasively has an enormous potential for characterising biological
changes in tissue, with the final goal of devising the appropriate com-
bination of quantitative MRI parameters for diagnosing and monitoring
neurological and psychiatric disorders. Although the most informative
way of combining several MRI parameters is not immediately obvious,
several examples found in the literature support the notion that some
complementary information can be obtained when using more than one
MRI technique. In the attempt to prove the specificity of the bound pool
fraction (F) from qMT and RD to myelin, Ou et al. (2009a) used retinal
ischaemia as a model of axonal damage with no demyelination in control
mice and of axonal damage with demyelination in shivered mice
(confirmed by immunohistochemistry). BPF and RD were significantly
different between control and shivered mice, but not between injured
and uninjured eyes. By contrast, AD and relative anisotropy differed
significantly between injured and uninjured eyes, but not betweenmouse
strains. These data suggest that MT is selectively sensitive to demyelin-
ation, while dMRI could potentially be sensitive to both demyelination
and axonal damage, although the well-known limitations of RD and AD
must be taken into account (Wheeler-Kingshott and Cercignani, 2009).
When qMT and dMRI were combined to characterise damage along the
cortico-spinal tract of patients with benign MS, it was consistently shown
that MT-derived PSR was significantly different from that of controls,
while FA was not. This mismatch was interpreted as indicative of
extensive demyelination in the absence of axonal loss (Spano et al.,
2010). A similar approach was followed by Narayanan et al. (2006), who
combined quantitative MT (as a marker of myelin density) with NAA/Cr
from 1H MRS (as a marker of axonal loss) to study the brain of patients
with MS. In this small sample, both BPF and NAA/CR were found to be
altered compared to healthy controls, but no correlation was found be-
tween the two, suggesting that axonal damage is not strictly related to
demyelination outside of visible lesions. Coupled with examples from
similar studies, these confirm that multiple contrasts can be comple-
mentary. Nevertheless, the aim of multi-modal imaging is to go beyond
the acquisition of multiple modalities analysed “in parallel”, and to
combine the different parameters to obtain novel biomarkers, greater
than the sum of their parts. By doing so, it should also become possible to
account for the collinearity of several MRI measures. So, what is the
optimal way of combining them, and what are the obstacles that may
prevent us from achieving this goal?
How to acquire multiple modalities
The first challenge of a multi-modal MRI protocol is in the acquisition
strategy. There are essentially two alternative approaches that can be
followed. The first one is to independently acquire the modalities of in-
terest, while the second one is to develop specialised acquisition
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diffusion and T2), accompanied by analytical models able to disentangle
the information provided by each single weighting.
The use of independent acquisition has the advantage of simplicity,
with sequences often available as commercial products, already available
quantitative models, and usually comparatively high signal-to-noise ratio
(SNR). However, bringing together data from separate acquisitions is not
without problems. This is especially relevant when the two modalities
require different type of readout. dMRI is typically obtained using single-
shot EPI, which suffers from geometric distortions (Jezzard and Balaban,
1995). As these effects are non-linear, simple image realignment or affine
registration do not compensate for them, and sophisticated approaches
are required to match them with data obtained from spin-warp acquisi-
tions. An example of the impact this geometric mismatch can have on
multi-modal protocol is given by Mohammadi et al. (2015), who com-
bined dMRI and MT to compute the g-ratio, i.e., the ratio of the inner to
the outer axonal diameter (Stikov et al., 2015) (discussed below). Due to
susceptibility distortions, some voxels of the corpus callosum showed an
unrealistically high g-ratio ~1. More convincing values are obtained
after correcting for distortions (see Fig. 1).
Depending on the combination of parameters of interest, this issue
might be addressed by serial acquisitions that share the same basic
readout. For example, multi-parameter mapping (MPM) (Helms et al.,
2009; Weiskopf et al., 2013) collects 3 multi-echo spoiled gradient-echo
sequences with predominant T1-, PD-, and MT-weighting, respectively.
The multiple echoes can be used to obtain estimates of T2*, but also for
averaging to boost the SNR of each acquisition. From the T1-and PD-
weighted scans it is straightforward to extract the amplitude of spoiled
gradient echo (apparent PD) and T1. These quantities can then be used to
derive the “MT saturation” (Helms et al., 2009), a phenomenological
quantity that, albeit not absolute, reflects the density of macromolecular
protons after removing the confounding effect of T1.
The idea of combining multiple gradient-echo sampling (for T2*-
decay) with other weightings was originally implemented for
measuring T2 and T2* at the same time (and therefore T2’) in the method
originally called gradient echo sampling of FID and echo (GESFIDE) (Ma
and Wehrli, 1996), and further developed into the gradient echo samplingFig. 1. Example of susceptibility-induced geometric distortions in the single-shell dMRI data and
b ¼ 0 maps (ib0) from the original (A,B,F,G) and susceptibility-distortion corrected dMRI data (C
not suffer from susceptibility artifacts. The spatial mismatch between anatomical structures in
ceptibility correction. The susceptibility-related mismatches between uncorrected dMRI and MT
of the voxels with an unrealistic g  1 at the edge of the genu (G)]. Reproduced under the ter
Copyright 2015 Mohammadi, Carey, Dick, Diedrichsen, Sereno, Reisert, Callaghan and Weisko
120of the spin echo (GESSE) by Yablonskiy and Haacke (1997). These are
early examples of combined acquisitions that remove some of the prob-
lems associated with independent measurements.
The same concept can be implemented within magnetization-
prepared 2 rapid acquisition gradient echoes (MP2RAGE (Marques
et al., 2010),), thus enabling T1, T2* and potentially magnetic suscep-
tibility to be mapped without field inhomogeneity bias (Metere
et al., 2017).
When data are acquired for the purpose of estimating sub-voxel
compartments, the geometric mismatch can have important conse-
quences, as even small differences in the resolution of separate acquisi-
tions can introduce bias, if images are differently interpolated (see
Fig. 2). Joint acquisitions can address this issue. These acquisitions also
tend to be more time-efficient than independent ones, although the
complexity of the mathematical models might impose some constraints
on signal-to-noise ratio (SNR). Examples were introduced already in the
late 90s, although restricted to in vitro experiments, due to the required
scan time.
Early studies in excised tissue (Andrews et al., 2006; Peled et al.,
1999; Stanisz et al., 1998) attempted to establish the relationship be-
tween T2-species and diffusion behaviour using some variant of the
diffusion-weighted (DW) Carr-Purcell-Meigoom-Gill (CPMG) sequence.
This acquisition consists of a standard pulsed-gradient spin-echo (PGSE)
preparation (van Dusschoten et al., 1996) followed by a CPMG train of
180 pulses. An echo is collected after each refocusing pulse thus map-
ping the effects of T2 decay. By altering the amplitude and the direction
of the diffusion gradients, it is possible to modulate the amount of
diffusion weighting and to evaluate anisotropy. Although a 2D-spectrum
could in principle be obtained through 2D inverse Laplace transform, in
practice this is an ill-posed problem. Alternatively, a T2-spectrum can be
obtained for each diffusion weighting separately, enabling the apparent
diffusion coefficient (ADC) of the water compartments corresponding to
each T2 peak to be studied. Andrews et al. (2006) further modified this
approach by adding a double inversion recovery (DIR) preparation to the
DW-CPMG. This allowed them to selectively suppress the signal from
non-myelin components exploiting T1 compartmentalisation instead of
T2. The results obtained in these separate experiments were fairlytheir effects on the estimated MR-based g-ratio map. The MR g-ratio and contrast-inverted
,D,H,I) of a representative subject were compared to the subjects' MT map (E,J), which did
the single-shell dMRI and MT data (see contours in red) was strongly reduced after sus-
maps led to a severe locally varying bias in the g-ratio maps [e.g., crosshair highlights one
ms of the Creative Commons Attribution License (CC BY) from Mohammadi et al. (2015).
pf.
Fig. 2. Effects of resampling raw data to fit with multi-compartment models. These images show the percentage difference in the estimated NODDI parameters when the raw data are
downsampled (top row) or upsampled (bottom row) before performing the fitting. The resulting maps were compared with maps that were resampled after the fitting. The original voxel
size was 2.5  2.5  2.5 mm3. While these effects are small, it is conceivable that combining 2 or more multi-component models that undergo different degrees of resampling might
introduce non-negligible errors.
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port the notion that the shortest T2 component (identified with myelin
water) is strongly anisotropic in diffusion (Andrews et al., 2006), while
others do not (Stanisz and Henkelman, 1998). One of the possible mo-
tivations for the incongruence is in the choice of the total number of T2
peaks to be modelled, which differed among these studies. An additional
complication is constituted by the fact that T2 compartments do not
necessarily correspond to diffusion compartments. For example, while
intra- and extra-cellular water compartments are expected to have
differing diffusion coefficients and behaviour (Assaf and Basser, 2005;
Stanisz et al., 1997), it is still under debate whether their T2 can be
distinguished (Bjarnason et al., 2005; Whittall et al., 1997). Therefore
characterising the diffusion properties of a specific T2 peak might not
have a straightforward interpretation.
Despite these limitations, the approach remains valid in principle,
and attempts to measure diffusion and T2 at the same time have recently
gained momentum, after the suggestion that DTI parameters might be
TE-dependent (Qin et al., 2009). While this might be simply explained by
SNR considerations (i.e., the difference in DTI parameters is caused by a
bias due to decreasing SNR at larger TEs), the most intriguing interpre-
tation is that TE determines the relative contribution of each water
compartment to the global signal. This view, however, suggests that a
comprehensive description of water compartments can only be gained by
developing joint models that take into account diffusion and T2 behav-
iour at the same time. Advances in hardware enable increasingly shorter
TEs to be used in conjunction with diffusion weighting (Fan et al., 2016).
Using such a system, Tax et al. (2017) obtained a dataset with b values
ranging from 500 to 7 000 smm2, and TE ranging from 47 to 127 ms.
Their data confirmed a dependency of DTI indices on TE, and suggested
that the combined diffusion and T2 spectrum might be resolved in the
human brain, providing novel information about water compartments in
white matter. Novel computational approaches able to resolve 2D spectra
have also been proposed (Benjamini and Basser, 2016).121Another interesting example of combined acquisitions was proposed
by De Santis et al. (2016), and combines inversion recovery (IR) with
dMRI. This sequence was developed for the purpose of mapping T1
(exploiting the IR preparation) along specific white matter tracts, even
when fibers cross within a single voxel (exploiting dMRI). The feasibility
of this approach in vivo was demonstrated, although the scan time re-
mains too long for clinical translation. With future advances in hardware
and sequence design, similar schemes are likely to become more
manageable and open the possibility of other contrast to be incorporated
in a single acquisition.
How to combine multiple modalities
The strategies used to combine MRI techniques can be broadly clas-
sified into 2 categories: data-driven approaches, which rely on multivar-
iate and/or machine learning methods; and model-driven approaches,
which attempt to combine parameters extracted by existing biophysical
or signal models to obtain new parameters, which are believed to be
more accurate or more specific to a given substrate than the original ones.
Data driven methods
The most informative way of combining MRI parameters is not
immediately obvious. A simple but effective way is using linear regres-
sion or similar methods. The interdependence between MRI parameters
in this case becomes useful and can be exploited to maximise the amount
of information derived from multi-parametric protocols. One parameter
that is sensitive to several biological substrates, such as T1, can be
modelled as a linear combination of other MR parameters, each used as a
surrogate of one or more of these substrates. The unexplained, or resid-
ual, variance is then assumed to measure the tissue component which
was not modelled by any of the surrogates. A few examples of successful
application of linear regression can be found in the literature. Ciccarelli
Fig. 3. Example of data-driven multi-modal application: multivariate myelin estimation model (MMEM). MMEM aimed to estimate a cortical myelin map using MTR, T2*, cortical
thickness (CT) and B0 orientation maps. The MMEM was divided into two steps. Firstly, two maps were estimated using multi-linear regressions: one using MTR, CT and B0 orientation
(ME_MTR) and one using T2*, CT and B0 orientation (ME_T2*). ME_MTR and ME_T2* maps represent myelin-correlated values corrected for partial volume effect and fibers orientation. In
order to merge MTR and T2* within the same framework, both linear regressions were performed with a common dependent variable (BMM). Secondly, the shared information between
ME_MTR and ME_T2* was extracted using ICA decomposition, for each subject. The ICA decomposed the signal into two components that are mathematically independent. The ‘so-called’
first component of the ICA was the source that shares the highest variance between ME_MTR and ME_T2*, the hypothesis being that the first component of the ICA was an indicator for
myelin content. Reproduced with permission from Mangeat et al. (2015). Copyright 2015 Elsevier Inc.
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then fed them into a statistical model to selectively estimate impairment
of mitochondrial metabolism. Lower residual variance in NAA, assumed
to reflect reducedmitochondrial metabolism, was associatedwith greater
clinical disability in MS, independent of structural damage. Similarly,
Callaghan et al. (2015) derived a linear relaxometry model, by
combining MTR (proportional to macromolecular content) and T2* (as a
proxy for iron content) to explain T1 variance.
These examples highlight one of the potential problems with MRI
biomarkers, namely their collinearity. T1 tends to correlate with T2 and
MT-derived quantities; T2* and MT might share some variance: overall
there is some overlap between the quantities that we are hoping to use to
measure differing underlying pathology. Some of these data-driven ap-
proaches attempt to remove this collinearity, and to isolate the unique
contribution of each specific technique.
More sophisticated approaches exploit multivariate methods, which122provide tools able to reduce the dimensionality of the data and to extract
from them some “latent variables” that better represent the characteris-
tics of the object under study. Examples include principal component
analysis (PCA), independent component analysis (ICA), and factor anal-
ysis, all of which re-express the data into a series of components obtained
as linear combinations of the original observations. The difference be-
tween these 3 methods is in the criteria used to define these linear
combinations. Two or more MRI modalities might be differently sensitive
to several microscopic properties of tissue at the same time. Applying a
data reduction approach might help to identify the common “latent”
source of contrast, ideally related to a specific substrate. A nice example
is provided by the multivariate myelin estimation model (MMEM) pro-
posed by Mangeat et al. (2015). Assuming that T2* and MTR are both
sensitive to myelin content, but also affected by other factors such as iron
content and tissue orientation (T2*) or inflammation and pH (MTR), they
combined them using ICA to identify their shared information, assumed
M. Cercignani, S. Bouyagoub NeuroImage 182 (2018) 117–127to reflect only myelin density in the human cortex (Fig. 3).
These methods are relatively simple to implement and potentially
useful for MRI modality combination. However, it must be noted that
they are unable to distinguish between the intrinsic variability of a
parameter due to the underlying microstructure, and the variability
dependent on measurement error and image inhomogeneity. In addition,
the interpretation of the resulting components is not always straight-
forward, and in some cases the latent variables may remain elusive in
their meaning.
Machine learning (ML) approaches constitute a more advanced class
of computational methods, which can be used to associate a combination
of MRI techniques with a range of microstructural features (Lemm et al.,
2011). ML methods rely on training an algorithm (most commonly some
kind of classifier) to identify the features of interest using real data
(Ashburner and Kloppel, 2011). Once trained, the classifier can be used
on previously unseen data. Although there are no published examples to
date, in the context of multimodal imaging, animal or post-mortem data
could be used to associate a combination of MRI parameters with a
specific tissue substrate validated with histology, and then translated into
clinical applications. One of the limitations of ML algorithm is that they
require a very large number of observations in order to produce reliable
associations (i.e., in order to be appropriately trained). This might not
always be possible in the context of biological samples.Model-driven methods
This family of methods differs from multivariate models because it
attempts to combine parameters extracted by existing biophysical or signal
models to obtain new parameters, which are believed to be more accu-
rate or more specific than the original ones. Biophysical models refer to
those that explain the MR signal as a function of biological properties –
example: axon diameter distribution (Alexander et al., 2010; Assaf et al.,
2008); whereas the signal models explain the MR signal using mathe-
matical or statistical properties – example: diffusion kurtosis (Jensen
et al., 2005).
A simple example of this kind is driven equilibrium single pulse
observation of T1 and T2 (DESPOT1 and DESPOT2) – a method forFig. 4. Model-driven example of multi-modal approach. By exploiting the sensitivity of NODD
fraction maps for intracellular, extracellular, CSF and myelin water (Bouyagoub et al., 2017).
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quences (Deoni et al., 2003). The SSFP signal equation is a function of
both T1 and T2, as both longitudinal and transverse magnetization are
brought into dynamic equilibrium through the application of repeated RF
pulses (Young et al., 1986). In order to disentangle T1 and T2, an inde-
pendent measure of either one is required. T1 is thus estimated using
spoiled gradient echo at variable flip angles (Bluml et al., 1993), thus
enabling T2 to be extracted. The method can be generalised to assume
multiple water components, characterised by separate relaxation times
(Deoni and Kolind, 2015). The multi-component version (mcDESPOT)
yields maps of the fractions of myelin water as well as of intra and
extra-cellular water (which cannot be distinguished using this method),
and has been used in multiple studies to characterise myelination and
other microstructural properties of tissue (Combes et al., 2017; Deoni
et al., 2012; Kitzler et al., 2012; Kolind et al., 2013).
The sensitivity of relaxometry to myelin can be further exploited by
combining these techniques with dMRI. While dMRI is highly sensitive to
tissue geometry and integrity, the long echo times typically required to
achieve sufficient diffusion weighting result in no signal contribution
from the fast decaying myelin component. In principle the complemen-
tarity of the 2 techniques can be exploited to obtain separate estimates of
the volumes of myelin, extra-cellular and intra-cellular spaces. Their
complementarity derives from the fact that multi-compartment models of
dMRI can easily separate the intra-cellular and the extra-cellular volume
fractions, but typically are not sensitive to myelin while mcDESPOT does
not distinguish intra- and extra-cellular spaces and measures their vol-
ume fractions as a combined sum. Bouyagoub et al. (2017) proposed a
simple model that requires the separate acquisition of mcDESPOT and
neurite orientation dispersion and density imaging (NODDI (Zhang et al.,
2012),) to yield separate the intra-cellular and extra-cellular volume
fractions maps along with myelin maps (Fig. 4).
As discussed in the joint acquisition section, multi-compartment
models of diffusion such as NODDI provide estimates of tissue fraction
that are relaxation-weighted. This means that acquisition parameters
such as TE might affect the results, but also that in the presence of
abnormal T2 values, the contribution of T2 and diffusion changes to
abnormal volume fractions cannot be disentangled. Even in the healthyI and mcDESPOT to different water compartments (top), it is possible to derive volume
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fraction, has much longer T2 than parenchyma, potentially affecting the
estimation of the isotropic diffusion component in white matter.
Combining T2 and diffusion in a single acquisition is feasible, as dis-
cussed above, but challenging. An alternative option is to independently
reconstruct the corresponding T2 spectrum, and then to feed these values
into the diffusion model. It was recently shown that combining mcDES-
POT, which provides estimates of intra/extra-cellular T2 and CSF T2, and
NODDI allows the latter to be adjusted to incorporate T2 values, ac-
counting for different T2 from different compartments and thus removing
the bias (Bouyagoub et al., 2016). See Fig. 5 for an example.
The local magnetic susceptibility is known to be affected by the
orientation of white matter fibers with respect to themainmagnetic field.
Other MRI contrasts that reflect iron and myelin characteristics might
have some dependency on the orientation of microstructure. Combining
these techniques with DTI enables the orientation-dependency of these
parameters to be investigated and modelled. This has been done for QSM
(Wharton and Bowtell, 2010), relaxometry (Gil et al., 2016)and the
macromolecular pool absorption lineshape in MT (Pampel et al., 2015).
A clear example of the augmented information provided by
combining two MRI techniques rather than focusing on a single contrast
is given by the g-ratio framework (Stikov et al., 2015), extensively
reviewed by other papers in this issue. The g-ratio is equal to the ratio of
the inner-to-outer diameter of a myelinated axon, and is known to be
associated with the speed of conduction along the axon (Rushton, 1934).
A method for estimating the so-called “aggregate g-ratio” was proposed,
building on simple geometric considerations and exploiting the respec-
tive sensitivities of MT imaging to myelin, and of dMRI to intra-axonal
water fraction (Stikov et al., 2015). Similar approaches based on
combining dMRI and relaxometry have also been suggested (Melbourne
et al., 2014). Because of its link with conduction velocity, the g-ratio can
be directly linked to axonal physiology and function, and represents an
ideal candidate tool for exploring the structure-function relationship.
Soon after its first introduction, this framework has been applied to the
study of brain maturation, and the variability within the healthyFig. 5. Exploiting multi-modal data to correct model bias. Fig. 5A shows the isotropic compo
istically high in the white matter, and one of the possible explanations for this is that NODDI
estimated by mcDESPOT to correct for this, yielding the maps shown on Fig. 5B.
124population (Cercignani et al., 2017; Dean et al., 2016; Mohammadi
et al., 2015).
An important observation with respect to model-driven approaches is
that they heavily rely on the biophysical modelling that links the signal
behaviour in each technique to biological parameters being correct. Any
bias would propagate into the multi-modal model, sometimes in an
unpredicted fashion. In addition to systematic bias, one must not forget
that any MRI parameter is affected by noise, and such noise will propa-
gate into the newly derived index resulting from their combination. In
some cases this effect can be estimated using the propagation of error
equation (Bevington and Robinson, 2002), which shows how combining
2 noisy measures may blur any signal beyond detection. A very simple
example is the combination of R2(¼1/T2) and R2*(¼1/T2*) for
computing R2’:
R'2 ¼ R2R*2 (1)
If the variances associated with R2 and R2* are, respectively, σ1 and σ2,
according to the propagation of error equation the variance associated











¼ σ21 þ σ22 (2)
MR fingerprinting
A completely new approach to multiparametric MRI is MR finger-
printing (MRF) (Ma et al., 2013). The MRF concept relies on the idea that
unique signal evolutions can be generated for different tissues through
the continuous variation of the acquisition sequence parameters. Once
the data are collected, pattern recognition can be used to associate each
signal evolution with a specific tissue defined by a dictionary containing
signal evolutions from all possible combinations of parameters. This
enables T1/T2 values to be associated with that specific tissue, as well asnent estimated by NODDI in a healthy participant. The isotropic fraction appears unreal-
fractions are relaxation-weighted. Bouyagoub et al. (2016) used each compartment's T2
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varied during acquisition). This is conceptually comparable to matching
a person's fingerprint to a database. MRF relies on the use of under-
sampling techniques, such as compressed sensing (Lustig et al., 2007) to
make the acquisition feasible in terms of scan time. Although still in its
infancy, MRF offers a series of advantages compared to standard MR
acquisition. It allows the collection of multiparametric data in a short
time; it is robust against field inhomogeneities and motion artifacts; and
it is extremely versatile. Providing a detailed review of MR fingerprinting
and its applications goes beyond the scope of this paper but we foresee an
increasing role for this approach in both clinical and research applica-
tions of MRI.
MRI and nuclear medicine
Multi-modal imaging can be thought as a more general approach,
going beyond the boundaries of MRI. By combining MRI with other,
complementary, neuroimaging techniques, such neurophysiological and
nuclear medicine methods, it is theoretically possible to characterise
more complex systems. For example, positron emission tomography
(PET) can exploit ligands to specific neurobiological substrates to provide
high specificity. Thanks to the spread of hybrid modalities, the marriage
between MRI and nuclear medicine is likely to be a long and happy one.
To date, examples of combined MRI and PET are still limited; neverthe-
less it was shown that biomarkers obtained by bringing together fluoro-
deoxy-glucose (FDG) PET, gray matter volumetrics and dMRI can better
explain memory disorders in patients with AD than each single metric in
isolation (Walhovd et al., 2009). Similarly, depressive symptoms in MS
can be partially explained by functional connectivity of the hippocampus
combined with imaging of PET ligands based on 8-kDa translocator
protein (TSPO), sensitive to the activation of microglia, and thus to acute
inflammation (Colasanti et al., 2014). More quantitative approaches are
likely to be developed in the near future.
Conclusions
Although some degree of overlap exists between the information
accessible through the main microstructural imaging techniques based
on MRI, their complementarity ensures that their combination can be
exploited to make the whole greater than the sum of its parts. While this
is generally accepted and supported by a large body of data, the best way
of bringing together different methods is still controversial. Multivariate
methods offer a simple solution, but a somewhat complicated interpre-
tation of the results. Joint models provide a more direct description of the
microstructure but require more complex data acquisition strategies, a
large degree of approximation, and are subject to a number of biases.
Ultimately validation will be essential to understand the real potential of
these methods, and their implementation will require the combined ef-
forts of physicists, computational scientists and biologists.
References
Alexander, D.C., Hubbard, P.L., Hall, M.G., Moore, E.A., Ptito, M., Parker, G.J.,
Dyrby, T.B., 2010. Orientationally invariant indices of axon diameter and density
from diffusion MRI. Neuroimage 52, 1374–1389.
Andrews, T.J., Osborne, M.T., Does, M.D., 2006. Diffusion of myelin water. Magn. Reson
Med. 56, 381–385.
Ashburner, J., Kloppel, S., 2011. Multivariate models of inter-subject anatomical
variability. Neuroimage 56, 422–439.
Assaf, Y., Basser, P.J., 2005. Composite hindered and restricted model of diffusion
(CHARMED) MR imaging of the human brain. Neuroimage 27, 48–58.
Assaf, Y., Blumenfeld-Katzir, T., Yovel, Y., Basser, P.J., 2008. AxCaliber: a method for
measuring axon diameter distribution from diffusion MRI. Magn. Reson Med. 59,
1347–1354.
Basser, P.J., Mattiello, J., LeBihan, D., 1994. MR diffusion tensor spectroscopy and
imaging. Biophys. J. 66, 259–267.
Beaulieu, C., 2009. The biological basis of diffusion anisotropy. Diffusion Mri
Quantitative Meas. Vivo Neuroanat. 105–126.125Benjamini, D., Basser, P.J., 2016. Use of marginal distributions constrained optimization
(MADCO) for accelerated 2D MRI relaxometry and diffusometry. J. Magn. Reson 271,
40–45.
Bevington, P.R., Robinson, D.K., 2002. Data Reduction and Error Analysis for the Physical
Sciences, third ed. McGraw-Hill.
Bjarnason, T.A., Vavasour, I.M., Chia, C.L., MacKay, A.L., 2005. Characterization of the
NMR behavior of white matter in bovine brain. Magn. Reson Med. 54, 1072–1081.
Bluml, S., Schad, L.R., Stepanow, B., Lorenz, W.J., 1993. Spin-lattice relaxation time
measurement by means of a TurboFLASH technique. Magn. Reson Med. 30, 289–295.
Bouyagoub, S., Dowell, N.G., Hurley, S.A., Wood, T.C., Cercignani, M., 2016.
Overestimation of CSF Fraction in NODDI: Possible Correction Techniques and the
Effect on Neurite Density and Orientation Dispersion Measures. ISMRM, Singapore.
Bouyagoub, S., Dowell, N.G., Clarke, C.L., Wood, T.C., Zhang, H., Cercignani, M., 2017.
Disentangling Myelination and Axonal Density Using NODDI and McDESPOT – a
Multimodal Microstructure Imaging Approach. ISMRM, Hawaii.
Buonocore, M.H., Maddock, R.J., 2015. Magnetic resonance spectroscopy of the brain: a
review of physical principles and technical methods. Rev. Neurosci. 26, 609–632.
Callaghan, M.F., Helms, G., Lutti, A., Mohammadi, S., Weiskopf, N., 2015. A general
linear relaxometry model of R1 using imaging data. Magn. Reson Med. 73,
1309–1314.
Cercignani, M., Giulietti, G., Dowell, N.G., Gabel, M., Broad, R., Leigh, P.N.,
Harrison, N.A., Bozzali, M., 2017. Characterizing axonal myelination within the
healthy population: a tract-by-tract mapping of effects of age and gender on the fiber
g-ratio. Neurobiol. Aging 49, 109–118.
Ciccarelli, O., Toosy, A.T., De Stefano, N., Wheeler-Kingshott, C.A., Miller, D.H.,
Thompson, A.J., 2010. Assessing neuronal metabolism in vivo by modeling imaging
measures. J. Neurosci. 30, 15030–15033.
Coatleven, J., Haddar, H., Li, J.R., 2014. A macroscopic model including membrane
exchange for diffusion mri. Siam J. Appl. Math. 74, 516–546.
Colasanti, A., Guo, Q., Muhlert, N., Giannetti, P., Onega, M., Newbould, R.D.,
Ciccarelli, O., Rison, S., Thomas, C., Nicholas, R., Muraro, P.A., Malik, O.,
Owen, D.R., Piccini, P., Gunn, R.N., Rabiner, E.A., Matthews, P.M., 2014. In vivo
assessment of brain white matter inflammation in multiple sclerosis with (18)F-
PBR111 PET. J. Nucl. Med. 55, 1112–1118.
Combes, A.J.E., Matthews, L., Lee, J.S., Li, D.K.B., Carruthers, R., Traboulsee, A.L.,
Barker, G.J., Palace, J., Kolind, S., 2017. Cervical cord myelin water imaging shows
degenerative changes over one year in multiple sclerosis but not neuromyelitis optica
spectrum disorder. Neuroimage Clin. 16, 17–22.
Connor, J.R., Menzies, S.L., St Martin, S.M., Mufson, E.J., 1990. Cellular distribution of
transferrin, ferritin, and iron in normal and aged human brains. J. Neurosci. Res. 27,
595–611.
De Santis, S., Assaf, Y., Jeurissen, B., Jones, D.K., Roebroeck, A., 2016. T1 relaxometry of
crossing fibres in the human brain. Neuroimage 141, 133–142.
Dean 3rd, D.C., O'Muircheartaigh, J., Dirks, H., Travers, B.G., Adluru, N., Alexander, A.L.,
Deoni, S.C., 2016. Mapping an index of the myelin g-ratio in infants using magnetic
resonance imaging. Neuroimage 132, 225–237.
Deoni, S.C., Dean 3rd, D.C., O'Muircheartaigh, J., Dirks, H., Jerskey, B.A., 2012.
Investigating white matter development in infancy and early childhood using myelin
water faction and relaxation time mapping. Neuroimage 63, 1038–1053.
Deoni, S.C., Kolind, S.H., 2015. Investigating the stability of mcDESPOT myelin water
fraction values derived using a stochastic region contraction approach. Magn. Reson
Med. 73, 161–169.
Deoni, S.C., Rutt, B.K., Peters, T.M., 2003. Rapid combined T1 and T2 mapping using
gradient recalled acquisition in the steady state. Magn. Reson Med. 49, 515–526.
Dousset, V., Grossman, R.I., Ramer, K.N., Schnall, M.D., Young, L.H., Gonzalez-
Scarano, F., Lavi, E., Cohen, J.A., 1992. Experimental allergic encephalomyelitis and
multiple sclerosis: lesion characterization with magnetization transfer imaging.
Radiology 182, 483–491.
Fan, Q., Witzel, T., Nummenmaa, A., Van Dijk, K.R., Van Horn, J.D., Drews, M.K.,
Somerville, L.H., Sheridan, M.A., Santillana, R.M., Snyder, J., Hedden, T., Shaw, E.E.,
Hollinshead, M.O., Renvall, V., Zanzonico, R., Keil, B., Cauley, S., Polimeni, J.R.,
Tisdall, D., Buckner, R.L., Wedeen, V.J., Wald, L.L., Toga, A.W., Rosen, B.R., 2016.
MGH-USC Human Connectome Project datasets with ultra-high b-value diffusion
MRI. Neuroimage 124, 1108–1114.
Gil, R., Khabipova, D., Zwiers, M., Hilbert, T., Kober, T., Marques, J.P., 2016. An in vivo
study of the orientation-dependent and independent components of transverse
relaxation rates in white matter. NMR Biomed. 29, 1780–1790.
Giulietti, G., Bozzali, M., Figura, V., Spano, B., Perri, R., Marra, C., Lacidogna, G.,
Giubilei, F., Caltagirone, C., Cercignani, M., 2012. Quantitative magnetization
transfer provides information complementary to grey matter atrophy in Alzheimer's
disease brains. Neuroimage 59, 1114–1122.
Haacke, E.M., Cheng, N.Y., House, M.J., Liu, Q., Neelavalli, J., Ogg, R.J., Khan, A.,
Ayaz, M., Kirsch, W., Obenaus, A., 2005. Imaging iron stores in the brain using
magnetic resonance imaging. Magn. Reson Imaging 23, 1–25.
Haacke, E.M., Liu, S., Buch, S., Zheng, W., Wu, D., Ye, Y., 2015. Quantitative
susceptibility mapping: current status and future directions. Magn. Reson Imaging 33,
1–25.
Hallgren, B., Sourander, P., 1958. The effect of age on the non-haemin iron in the human
brain. J. Neurochem. 3, 41–51.
Harrison, N.A., Cooper, E., Dowell, N.G., Keramida, G., Voon, V., Critchley, H.D.,
Cercignani, M., 2015. Quantitative magnetization transfer imaging as a biomarker for
effects of systemic inflammation on the brain. Biol. Psychiatry 78, 49–57.
Hattingen, E., Raab, P., Franz, K., Lanfermann, H., Setzer, M., Gerlach, R., Zanella, F.E.,
Pilatus, U., 2008. Prognostic value of choline and creatine in WHO grade II gliomas.
Neuroradiology 50, 759–767.
M. Cercignani, S. Bouyagoub NeuroImage 182 (2018) 117–127Helms, G., Dathe, H., Kallenberg, K., Dechent, P., 2008. High-resolution maps of
magnetization transfer with inherent correction for RF inhomogeneity and T1
relaxation obtained from 3D FLASH MRI. Magn. Reson Med. 60, 1396–1407.
Helms, G., Draganski, B., Frackowiak, R., Ashburner, J., Weiskopf, N., 2009. Improved
segmentation of deep brain grey matter structures using magnetization transfer (MT)
parameter maps. Neuroimage 47, 194–198.
Henkelman, R.M., Huang, X., Xiang, Q.S., Stanisz, G.J., Swanson, S.D., Bronskill, M.J.,
1993. Quantitative interpretation of magnetization transfer. Magn. Reson Med. 29,
759–766.
Henkelman, R.M., Stanisz, G.J., Graham, S.J., 2001. Magnetization transfer in MRI: a
review. NMR Biomed. 14, 57–64.
Howe, F.A., Barton, S.J., Cudlip, S.A., Stubbs, M., Saunders, D.E., Murphy, M., Wilkins, P.,
Opstad, K.S., Doyle, V.L., McLean, M.A., Bell, B.A., Griffiths, J.R., 2003. Metabolic
profiles of human brain tumors using quantitative in vivo 1H magnetic resonance
spectroscopy. Magn. Reson Med. 49, 223–232.
Jensen, J.H., Helpern, J.A., Ramani, A., Lu, H., Kaczynski, K., 2005. Diffusional kurtosis
imaging: the quantification of non-gaussian water diffusion by means of magnetic
resonance imaging. Magn. Reson Med. 53, 1432–1440.
Jezzard, P., Balaban, R.S., 1995. Correction for geometric distortion in echo planar
images from B0 field variations. Magn. Reson Med. 34, 65–73.
Kaden, E., Alexander, D.C., 2013. Can T2-spectroscopy resolve submicrometer axon
diameters? Inf. Process Med. Imaging 23, 607–618.
Kitzler, H.H., Su, J., Zeineh, M., Harper-Little, C., Leung, A., Kremenchutzky, M.,
Deoni, S.C., Rutt, B.K., 2012. Deficient MWF mapping in multiple sclerosis using 3D
whole-brain multi-component relaxation MRI. Neuroimage 59, 2670–2677.
Kleim, J.A., Barbay, S., Cooper, N.R., Hogg, T.M., Reidel, C.N., Remple, M.S., Nudo, R.J.,
2002. Motor learning-dependent synaptogenesis is localized to functionally
reorganized motor cortex. Neurobiol. Learn Mem. 77, 63–77.
Kolind, S., Sharma, R., Knight, S., Johansen-Berg, H., Talbot, K., Turner, M.R., 2013.
Myelin imaging in amyotrophic and primary lateral sclerosis. Amyotroph. Lateral
Scler. Front. Degener. 14, 562–573.
Kucharczyk, W., Macdonald, P.M., Stanisz, G.J., Henkelman, R.M., 1994. Relaxivity and
magnetization transfer of white matter lipids at MR imaging: importance of
cerebrosides and pH. Radiology 192, 521–529.
LeBihan, D., 1990. IVIM method measures diffusion and perfusion. Diagn Imaging (San
Franc) 12, 133–136.
Lemm, S., Blankertz, B., Dickhaus, T., Muller, K.R., 2011. Introduction to machine
learning for brain imaging. Neuroimage 56, 387–399.
Liu, T., Spincemaille, P., de Rochefort, L., Kressler, B., Wang, Y., 2009. Calculation of
susceptibility through multiple orientation sampling (COSMOS): a method for
conditioning the inverse problem from measured magnetic field map to susceptibility
source image in MRI. Magn. Reson Med. 61, 196–204.
Louie, E.A., Gochberg, D.F., Does, M.D., Damon, B.M., 2009. Transverse relaxation and
magnetization transfer in skeletal muscle: effect of pH. Magn. Reson Med. 61,
560–569.
Lustig, M., Donoho, D., Pauly, J.M., 2007. Sparse MRI: the application of compressed
sensing for rapid MR imaging. Magn. Reson Med. 58, 1182–1195.
Ma, D., Gulani, V., Seiberlich, N., Liu, K., Sunshine, J.L., Duerk, J.L., Griswold, M.A.,
2013. Magnetic resonance fingerprinting. Nature 495, 187–192.
Ma, J., Wehrli, F.W., 1996. Method for image-based measurement of the reversible and
irreversible contribution to the transverse-relaxation rate. J. Magn. Reson B 111,
61–69.
MacKay, A., Laule, C., Vavasour, I., Bjarnason, T., Kolind, S., Madler, B., 2006. Insights
into brain microstructure from the T2 distribution. Magn. Reson Imaging 24,
515–525.
MacKay, A., Whittall, K., Adler, J., Li, D., Paty, D., Graeb, D., 1994. In vivo visualization of
myelin water in brain by magnetic resonance. Magn. Reson Med. 31, 673–677.
Mangeat, G., Govindarajan, S.T., Mainero, C., Cohen-Adad, J., 2015. Multivariate
combination of magnetization transfer, T2* and B0 orientation to study the myelo-
architecture of the in vivo human cortex. Neuroimage 119, 89–102.
Marques, J.P., Kober, T., Krueger, G., van der Zwaag, W., Van de Moortele, P.F.,
Gruetter, R., 2010. MP2RAGE, a self bias-field corrected sequence for improved
segmentation and T1-mapping at high field. Neuroimage 49, 1271–1281.
Melbourne, A., Eaton-Rosen, Z., De Vita, E., Bainbridge, A., Cardoso, M.J., Price, D.,
Cady, E., Kendall, G.S., Robertson, N.J., Marlow, N., Ourselin, S., 2014. Multi-modal
measurement of the myelin-to-axon diameter g-ratio in preterm-born neonates and
adult controls. Med. Image Comput. Comput. Assist. Interv. 17, 268–275.
Metere, R., Kober, T., Moller, H.E., Schafer, A., 2017. Simultaneous quantitative MRI
mapping of T1, T2* and Magnetic Susceptibility with Multi-Echo MP2RAGE. PLoS
One 12, e0169265.
Mezer, A., Yeatman, J.D., Stikov, N., Kay, K.N., Cho, N.J., Dougherty, R.F., Perry, M.L.,
Parvizi, J., Hua le, H., Butts-Pauly, K., Wandell, B.A., 2013. Quantifying the local
tissue volume and composition in individual brains with magnetic resonance
imaging. Nat. Med. 19, 1667–1672.
Mohammadi, S., Carey, D., Dick, F., Diedrichsen, J., Sereno, M.I., Reisert, M.,
Callaghan, M.F., Weiskopf, N., 2015. Whole-brain in-vivo measurements of the
axonal g-ratio in a group of 37 healthy volunteers. Front. Neurosci. 9, 441.
Narayanan, S., Francis, S.J., Sled, J.G., Santos, A.C., Antel, S., Levesque, I., Brass, S.,
Lapierre, Y., Sappey-Marinier, D., Pike, G.B., Arnold, D.L., 2006. Axonal injury in the
cerebral normal-appearing white matter of patients with multiple sclerosis is related
to concurrent demyelination in lesions but not to concurrent demyelination in
normal-appearing white matter. Neuroimage 29, 637–642.
Neeb, H., Zilles, K., Shah, N.J., 2006. Fully-automated detection of cerebral water content
changes: study of age- and gender-related H2O patterns with quantitative MRI.
Neuroimage 29, 910–922.126Ordidge, R.J., Gorell, J.M., Deniau, J.C., Knight, R.A., Helpern, J.A., 1994. Assessment of
relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3
Tesla. Magn. Reson Med. 32, 335–341.
Ou, X., Sun, S.W., Liang, H.F., Song, S.K., Gochberg, D.F., 2009a. The MT pool size ratio
and the DTI radial diffusivity may reflect the myelination in shiverer and control
mice. NMR Biomed. 22, 480–487.
Ou, X., Sun, S.W., Liang, H.F., Song, S.K., Gochberg, D.F., 2009b. Quantitative
magnetization transfer measured pool-size ratio reflects optic nerve myelin content in
ex vivo mice. Magn. Reson Med. 61, 364–371.
Pampel, A., Muller, D.K., Anwander, A., Marschner, H., Moller, H.E., 2015. Orientation
dependence of magnetization transfer parameters in human white matter.
Neuroimage 114, 136–146.
Peled, S., Cory, D.G., Raymond, S.A., Kirschner, D.A., Jolesz, F.A., 1999. Water diffusion,
T(2), and compartmentation in frog sciatic nerve. Magn. Reson Med. 42, 911–918.
Pierpaoli, C., Jezzard, P., Basser, P.J., Barnett, A., Di Chiro, G., 1996. Diffusion tensor MR
imaging of the human brain. Radiology 201, 637–648.
Qin, W., Yu, C.S., Zhang, F., Du, X.Y., Jiang, H., Yan, Y.X., Li, K.C., 2009. Effects of echo
time on diffusion quantification of brain white matter at 1.5 T and 3.0 T. Magn.
Reson Med. 61, 755–760.
Rushton, W.A., 1934. A physical analysis of the relation between threshold and interpolar
length in the electric excitation of medullated nerve. J. Physiol. 82, 332–352.
Scholz, J., Klein, M.C., Behrens, T.E., Johansen-Berg, H., 2009. Training induces changes
in white-matter architecture. Nat. Neurosci. 12, 1370–1371.
Schweser, F., Deistung, A., Sommer, K., Reichenbach, J.R., 2013. Toward online
reconstruction of quantitative susceptibility maps: superfast dipole inversion. Magn.
Reson Med. 69, 1582–1594.
Shmueli, K., de Zwart, J.A., van Gelderen, P., Li, T.Q., Dodd, S.J., Duyn, J.H., 2009.
Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn.
Reson Med. 62, 1510–1522.
Song, S.K., Yoshino, J., Le, T.Q., Lin, S.J., Sun, S.W., Cross, A.H., Armstrong, R.C., 2005.
Demyelination increases radial diffusivity in corpus callosum of mouse brain.
Neuroimage 26, 132–140.
Spano, B., Cercignani, M., Basile, B., Romano, S., Mannu, R., Centonze, D.,
Caltagirone, C., Bramanti, P., Nocentini, U., Bozzali, M., 2010. Multiparametric MR
investigation of the motor pyramidal system in patients with 'truly benign' multiple
sclerosis. Mult. Scler. 16, 178–188.
Stanisz, G.J., Henkelman, R.M., 1998. Diffusional anisotropy of T2 components in bovine
optic nerve. Magn. Reson Med. 40, 405–410.
Stanisz, G.J., Li, J.G., Wright, G.A., Henkelman, R.M., 1998. Water dynamics in human
blood via combined measurements of T2 relaxation and diffusion in the presence of
gadolinium. Magn. Reson Med. 39, 223–233.
Stanisz, G.J., Szafer, A., Wright, G.A., Henkelman, R.M., 1997. An analytical model of
restricted diffusion in bovine optic nerve. Magn. Reson Med. 37, 103–111.
Stanisz, G.J., Webb, S., Munro, C.A., Pun, T., Midha, R., 2004. MR properties of excised
neural tissue following experimentally induced inflammation. Magn. Reson Med. 51,
473–479.
Stikov, N., Campbell, J.S., Stroh, T., Lavelee, M., Frey, S., Novek, J., Nuara, S., Ho, M.K.,
Bedell, B.J., Dougherty, R.F., Leppert, I.R., Boudreau, M., Narayanan, S., Duval, T.,
Cohen-Adad, J., Picard, P.A., Gasecka, A., Cote, D., Pike, G.B., 2015. In vivo histology
of the myelin g-ratio with magnetic resonance imaging. Neuroimage 118, 397–405.
Tax, C.M.W., Rudrapatna, U.S., Witzel, T., Jones, D.K., 2017. Disentangling in Two
Dimensions in the Living Human Brain: Feasibility of Relaxometry-diffusometry
Using Ultra-strong Gradients. ISMRM, Hawaii, USA.
Tofts, P.S., 2003a. Concepts: measurement and MR. In: Tofts, P.S. (Ed.), Quantitative MRI
of the Brain: Measuring Changes Caused by Disease. Wiley.
Tofts, P.S., 2003b. PD: proton Density of tissue water. In: Tofts, P.S. (Ed.), Quantitative
MRI of the Brain. Wiley, Chicester, West Sussex, England.
Turati, L., Moscatelli, M., Mastropietro, A., Dowell, N.G., Zucca, I., Erbetta, A.,
Cordiglieri, C., Brenna, G., Bianchi, B., Mantegazza, R., Cercignani, M., Baggi, F.,
Minati, L., 2015. In vivo quantitative magnetization transfer imaging correlates with
histology during de- and remyelination in cuprizone-treated mice. NMR Biomed. 28,
327–337.
van Dusschoten, D., Moonen, C.T., de Jager, P.A., Van As, H., 1996. Unraveling diffusion
constants in biological tissue by combining Carr-Purcell-Meiboom-Gill imaging and
pulsed field gradient NMR. Magn. Reson Med. 36, 907–913.
Walhovd, K.B., Fjell, A.M., Amlien, I., Grambaite, R., Stenset, V., Bjornerud, A.,
Reinvang, I., Gjerstad, L., Cappelen, T., Due-Tonnessen, P., Fladby, T., 2009.
Multimodal imaging in mild cognitive impairment: metabolism, morphometry and
diffusion of the temporal-parietal memory network. Neuroimage 45, 215–223.
Walhovd, K.B., Johansen-Berg, H., Karadottir, R.T., 2014. Unraveling the secrets of white
matter–bridging the gap between cellular, animal and human imaging studies.
Neuroscience 276, 2–13.
Wang, Y., Liu, T., 2015. Quantitative susceptibility mapping (QSM): decoding MRI data
for a tissue magnetic biomarker. Magn. Reson Med. 73, 82–101.
Weiskopf, N., Suckling, J., Williams, G., Correia, M.M., Inkster, B., Tait, R., Ooi, C.,
Bullmore, E.T., Lutti, A., 2013. Quantitative multi-parameter mapping of R1, PD(*),
MT, and R2(*) at 3T: a multi-center validation. Front. Neurosci. 7, 95.
Wharton, S., Bowtell, R., 2010. Whole-brain susceptibility mapping at high field: a
comparison of multiple- and single-orientation methods. Neuroimage 53, 515–525.
Wharton, S., Schafer, A., Bowtell, R., 2010. Susceptibility mapping in the human brain
using threshold-based k-space division. Magn. Reson Med. 63, 1292–1304.
Wheeler-Kingshott, C.A., Cercignani, M., 2009. About “axial” and “radial” diffusivities.
Magn. Reson Med. 61, 1255–1260.
Whittall, K.P., MacKay, A.L., Graeb, D.A., Nugent, R.A., Li, D.K., Paty, D.W., 1997. In vivo
measurement of T2 distributions and water contents in normal human brain. Magn.
Reson Med. 37, 34–43.
M. Cercignani, S. Bouyagoub NeuroImage 182 (2018) 117–127Wolff, S.D., Balaban, R.S., 1989. Magnetization transfer contrast (MTC) and tissue water
proton relaxation in vivo. Magn. Reson Med. 10, 135–144.
Yablonskiy, D.A., Haacke, E.M., 1997. An MRI method for measuring T2 in the presence
of static and RF magnetic field inhomogeneities. Magn. Reson Med. 37, 872–876.
Young, I.R., Burl, M., Bydder, G.M., 1986. Comparative efficiency of different pulse
sequences in MR imaging. J. Comput. Assist. Tomogr. 10, 271–286.127Zatorre, R.J., Fields, R.D., Johansen-Berg, H., 2012. Plasticity in gray and white:
neuroimaging changes in brain structure during learning. Nat. Neurosci. 15,
528–536.
Zhang, H., Schneider, T., Wheeler-Kingshott, C.A., Alexander, D.C., 2012. NODDI:
practical in vivo neurite orientation dispersion and density imaging of the human
brain. Neuroimage 61, 1000–1016.
